About Technology Issues FAQ

Links

Randomized Phase II Open-Label Study of mFOLFOX6 in Combination With Linifanib or Bevacizumab for Metastatic Colorectal Cancer

Randomized Phase II Open-Label Study of mFOLFOX6 in Combination With Linifanib or Bevacizumab for Metastatic Colorectal Cancer — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.